vs
Side-by-side financial comparison of SharpLink Gaming, Inc. (SBET) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.
Xilio Therapeutics, Inc. is the larger business by last-quarter revenue ($13.7M vs $10.8M, roughly 1.3× SharpLink Gaming, Inc.). SharpLink Gaming, Inc. runs the higher net margin — 961.6% vs 75.7%, a 885.9% gap on every dollar of revenue. Xilio Therapeutics, Inc. produced more free cash flow last quarter ($-2.1M vs $-6.3M).
Bonne Terre Limited is a British-based gambling company, owned by Flutter Entertainment, with headquarters in Leeds, West Yorkshire and offices in Solihull. Sky Betting & Gaming consists of five core brands: Sky Bet, Sky Vegas, Sky Casino, Sky Poker and Sky Bingo.
Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.
SBET vs XLO — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $10.8M | $13.7M |
| Net Profit | $104.3M | $10.4M |
| Gross Margin | — | — |
| Operating Margin | — | -86.5% |
| Net Margin | 961.6% | 75.7% |
| Revenue YoY | 1129.9% | — |
| Net Profit YoY | 11880.2% | 179.1% |
| EPS (diluted) | $0.62 | $-3.74 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $13.7M | ||
| Q3 25 | $10.8M | $19.1M | ||
| Q2 25 | $697.3K | $8.1M | ||
| Q1 25 | $741.7K | $2.9M | ||
| Q4 24 | $823.1K | — | ||
| Q3 24 | $881.7K | — | ||
| Q2 24 | $981.3K | — | ||
| Q1 24 | $975.9K | — |
| Q4 25 | — | $10.4M | ||
| Q3 25 | $104.3M | $-16.3M | ||
| Q2 25 | $-103.4M | $-15.8M | ||
| Q1 25 | $-974.9K | $-13.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-885.1K | — | ||
| Q2 24 | $-463.0K | — | ||
| Q1 24 | $12.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 30.0% | — | ||
| Q1 25 | 17.8% | — | ||
| Q4 24 | 20.2% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 28.5% | — | ||
| Q1 24 | 29.4% | — |
| Q4 25 | — | -86.5% | ||
| Q3 25 | — | -10.1% | ||
| Q2 25 | -14826.0% | -177.7% | ||
| Q1 25 | -124.8% | -472.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -90.4% | — | ||
| Q2 24 | -122.8% | — | ||
| Q1 24 | -172.6% | — |
| Q4 25 | — | 75.7% | ||
| Q3 25 | 961.6% | -85.4% | ||
| Q2 25 | -14832.1% | -196.0% | ||
| Q1 25 | -131.4% | -452.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -100.4% | — | ||
| Q2 24 | -47.2% | — | ||
| Q1 24 | 1265.5% | — |
| Q4 25 | — | $-3.74 | ||
| Q3 25 | $0.62 | $-0.11 | ||
| Q2 25 | $-4.27 | $-0.16 | ||
| Q1 25 | $-1.84 | $-0.18 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-3.02 | — | ||
| Q2 24 | $-1.35 | — | ||
| Q1 24 | $40.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $137.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.1B | $35.3M |
| Total Assets | $3.1B | $154.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $137.5M | ||
| Q3 25 | — | $103.8M | ||
| Q2 25 | — | $121.6M | ||
| Q1 25 | — | $89.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $35.3M | ||
| Q3 25 | $3.1B | $-8.1M | ||
| Q2 25 | $452.5M | $7.1M | ||
| Q1 25 | $2.1M | $10.7M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.0M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | — | $154.7M | ||
| Q3 25 | $3.1B | $133.7M | ||
| Q2 25 | $453.9M | $133.8M | ||
| Q1 25 | $2.8M | $103.7M | ||
| Q4 24 | $2.6M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $3.8M | — | ||
| Q1 24 | $5.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-2.0M |
| Free Cash FlowOCF − Capex | $-6.3M | $-2.1M |
| FCF MarginFCF / Revenue | -57.9% | -15.3% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | -0.06× | -0.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-2.0M | ||
| Q3 25 | $-6.3M | $-17.5M | ||
| Q2 25 | $-1.6M | $-14.5M | ||
| Q1 25 | $-514.1K | $29.0M | ||
| Q4 24 | $-22.8M | — | ||
| Q3 24 | $-591.2K | — | ||
| Q2 24 | $-1.7M | — | ||
| Q1 24 | $-19.3M | — |
| Q4 25 | — | $-2.1M | ||
| Q3 25 | $-6.3M | — | ||
| Q2 25 | — | $-14.9M | ||
| Q1 25 | — | $29.0M | ||
| Q4 24 | $-22.8M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-19.3M | — |
| Q4 25 | — | -15.3% | ||
| Q3 25 | -57.9% | — | ||
| Q2 25 | — | -184.0% | ||
| Q1 25 | — | 988.3% | ||
| Q4 24 | -2772.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1977.2% | — |
| Q4 25 | — | 0.7% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | — | 5.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | — | -0.19× | ||
| Q3 25 | -0.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.56× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBET
| ETH Staking Segmet | $10.3M | 95% |
| Other | $569.8K | 5% |
XLO
Segment breakdown not available.
